The French -Q32’s ....thoughts ?24 Apr 2021 02:11
With this extract in the RNS below , cant help but to think why. Just a thought, we all know the French need two gene tests to qualify for reimbursement.
Maybe they fancy a bit of near patient infrastructure? Got some machines going as DHSC dusted us on Phase ll. Good money to be made on the 2G PROmate, like HP on printers..... it’s all in the ink. Would be a massive win, with 60% (last we knew) of shares held over the water.
***********************************
Expansion of PROmateTM COVID-19 PCR portfolio for workflow efficiency in a near-
to-patient setting
>Development of two-gene target test, launch expected May 2021